Kosan ends KOS-862 NSCLC development

KOSN discontinued development of KOS-862 (Epothilone D) to treat non-small cell lung

Read the full 124 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE